Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (ASZ1) is a germ cell-specific protein encoded by the ASZ1 gene in humans[3][5][10]. It is characterized by the presence of ankyrin repeats, a SAM (Sterile Alpha Motif) domain, and a basic leucine zipper domain[11][2][6]. ASZ1 is primarily expressed in the cytoplasm of germ cells and is essential for spermatogenesis in males, playing a role in the repression of transposable elements, particularly via the piRNA pathway, thus maintaining genomic stability in germ cells[2][11][6]. Disruption or mutations in ASZ1 are associated with defects in spermatogenesis and male infertility[2]. There are no known pharmacological agents or drugs targeting ASZ1, and it is not classified as a therapeutic target or receptor. Its functional and disease relevance is specific to germ cell biology and does not extend to other typical drug target categories.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (ASZ1).